[1]
|
Torre, L.A., Bray, F., Siegel, R.L., et al. (2015) Global Cancer Statistics, 2012. CA: A Cancer Journal for Clinicians, 65, 87-108. https://doi.org/10.3322/caac.21262
|
[2]
|
Sung, H., Ferlay, J., Siegel, R. L., et al. (2021) Global Cancer Sta-tistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[3]
|
Makita, S., Maruyama, D., Maeshima, A. M., et al. (2016) Clinical Fea-tures and Outcomes of 139 Japanese Patients with Hodgkin Lymphoma. International Journal of Hematology, 104, 236-244.
https://doi.org/10.1007/s12185-016-2007-1
|
[4]
|
Meng, J., Chang, C., Pan, H., et al. (2018) Epidemiologic Char-acteristics of Malignant Lymphoma in Hubei, China: A Single-Center 5-Year Retrospective Study. Medicine, 97, e12120. https://doi.org/10.1097/MD.0000000000012120
|
[5]
|
时云飞, 李向红. 北方地区235例霍奇金淋巴瘤临床病理特征及其EB病毒感染的相关性分析[J]. 中华病理学杂志, 2015, 44(2): 84-89.
|
[6]
|
刘彤华. 诊断病理学[J]. 中国医刊, 2019, 54(2): 233.
|
[7]
|
中国抗癌协会淋巴瘤专业委员会, 中国医师协会肿瘤医师分会, 中国医疗保健国际交流促进会肿瘤内科分会. 中国淋巴瘤治疗指南(2021年版) [J]. 中华肿瘤杂志, 2021, 43(7): 707-735.
|
[8]
|
郭春阳. 118例原发性结外淋巴瘤临床病理分析[J]. 系统医学, 2017, 2(6): 7-9.
|
[9]
|
St-Pierre, F., Broski, S.M., LaPlant, B.R., et al. (2020) Fluorodeoxyglucose-Positron Emission Tomography Predicts Bone Marrow Involvement in the Staging of Follicular Lymphoma. The Oncologist, 25, 689-695.
https://doi.org/10.1634/theoncologist.2019-0952
|
[10]
|
高帆, 克晓燕, 王晶, 等. 骨髓穿刺物的检测对非霍奇金淋巴瘤患者骨髓受累的诊断和患者预后评估的价值[J]. 中国实验血液学杂志, 2020, 28(2): 488-494.
|
[11]
|
Saiki, Y., Tomita, N., Uchida, A., et al. (2021) Biopsy Remains Indispensable for Evaluating Bone Marrow Involvement in DLBCL Patients Despite the Use of Positron Emission Tomography. International Journal of Hematology, 113, 675-681. https://doi.org/10.1007/s12185-021-03080-3
|
[12]
|
Sorigue, M., Cañamero, E. and Miljkovic, M.D. (2021) System-atic Review of Staging Bone Marrow Involvement in B Cell Lymphoma by Flow Cytometry. Blood Reviews, 47, Article ID: 100778.
https://doi.org/10.1016/j.blre.2020.100778
|
[13]
|
Adams, H.J., Nievelstein, R.A. and Kwee, T.C. (2015) Opportuni-ties and Limitations of Bone Marrow Biopsy and Bone Marrow FDG-PET in Lymphoma. Blood Reviews, 29, 417-425. https://doi.org/10.1016/j.blre.2015.06.003
|
[14]
|
Arber, D.A. and George, T.I. (2005) Bone Marrow Biopsy In-volvement by Non-Hodgkin’s Lymphoma: Frequency of Lymphoma Types, Patterns, Blood Involvement, and Discord-ance with Other Sites in 450 Specimens. The American Journal of Surgical Pathology, 29, 1549-1557. https://doi.org/10.1097/01.pas.0000182405.65041.8b
|
[15]
|
Sovani, V., Harvey, C., Haynes, A., et al. (2014) Bone Marrow Trephine Biopsy Involvement by Lymphoma: Review of Histopathological Features in 511 Specimens and Cor-relation with Diagnostic Biopsy, Aspirate and Peripheral Blood Findings. Journal of Clinical Pathology, 67, 389-395. https://doi.org/10.1136/jclinpath-2013-201520
|
[16]
|
陈青, 朱璐婷, 岑溪南, 等. 不同病理类型淋巴瘤骨髓侵犯的发生率[J]. 中国实验血液学杂志, 2018, 26(3): 765-771.
|
[17]
|
Freedman, A. and Jacobsen, E. (2020) Follicular Lymphoma: 2020 Update on Diagnosis and Management. American Journal of Hematology, 95, 316-327. https://doi.org/10.1002/ajh.25696
|
[18]
|
Cabezas-Quintario, M.A., Gomez, P., Yuste-Del Pozo, V., et al. (2016) Bone Marrow Trephine Biopsy Involvement by Lymphoma: Pattern of Involvement and Concordance with Flow Cytom-etry, in 10 Years from a Single Institution. Clinical and Translational Oncology, 18, 537-540. https://doi.org/10.1007/s12094-015-1393-9
|
[19]
|
Sultan, S., Irfan, S.M., Parveen, S., et al. (2016) Frequency and Pattern of Bone Marrow Infiltration in Classical Hodgkin’s Lymphoma: Experience from Southern Pakistan. Asian Pa-cific Journal of Cancer Prevention, 17, 1857-1859.
https://doi.org/10.7314/APJCP.2016.17.4.1857
|
[20]
|
Gerlach, M., Juskevicius, D., Vela, V., Dirnhofer, S. and Tzankov, A. (2020) Bone Marrow Infiltration of Angioimmunoblastic T-Cell Lymphoma: Identification and Prognostic Impact of Histologic Patterns and Diagnostic Application of Ancillary Phenotypic and Molecular Analyses. Archives of Pathology & Laboratory Medicine, 144, 602-611.
https://doi.org/10.5858/arpa.2019-0007-OA
|
[21]
|
Dogan, A. and Morice, W.G. (2004) Bone Marrow Histopathol-ogy in Peripheral T-Cell Lymphomas. British Journal of Haematology, 127, 140-154. https://doi.org/10.1111/j.1365-2141.2004.05144.x
|
[22]
|
Li, H.-N., Wang, R.-C., Chen, C.-H., et al. (2022) Distinc-tive Patterns of Marrow Involvement by Classic Hodgkin Lymphoma Are Clues for Diagnosis and Subtyping. Virchows Archiv: An International Journal of Pathology, 480, 899-907. https://doi.org/10.1007/s00428-022-03273-z
|
[23]
|
Sudalaimuthu, M. and Basu, D. (2017) Clinicopathological Fea-tures of Bone Marrow Infiltration in Hodgkin Lymphoma. Should Bone Marrow Staging Be Done Only in High Risk Patients? Türk Patoloji Dergisi/Turkish Journal of Pathology, 33, 129-133. https://doi.org/10.5146/tjpath.2016.01383
|
[24]
|
Torlakovic, E., Torlakovic, G. and Brunning, R.D. (2002) Follicular Pattern of Bone Marrow Involvement by Follicular Lymphoma. American Journal of Clinical Pathology, 118, 780-786.
https://doi.org/10.1309/EG2M-YHB9-WEFW-7H1R
|
[25]
|
Vassilakopoulos, T.P., Angelopoulou, M.K., Constan-tinou, N., et al. (2005) Development and Validation of a Clinical Prediction Rule for Bone Marrow Involvement in Pa-tients with Hodgkin Lymphoma. Blood, 105, 1875-1880.
https://doi.org/10.1182/blood-2004-01-0379
|
[26]
|
丁雅雯, 王芃堉, 焦文静, 等. 弥漫大B细胞淋巴瘤骨髓侵犯形态学及免疫表型特点分析[J]. 天津医药, 2020, 48(3): 204-208.
|
[27]
|
徐小艳, 冯智坤, 王璇, 等. 弥漫大B细胞淋巴瘤侵犯骨髓7例临床病理分析[J]. 临床与实验病理学杂志, 2021, 37(9): 1119-1121.
|
[28]
|
肖家诚, 金晓龙, 袁菲. 骨髓活检组织淋巴瘤的病理诊断和分型[J]. 中华病理学杂志, 2004, 33(2): 120-124.
|
[29]
|
张会超, 张燕林, 谢建兰, 周小鸽. 霍奇金淋巴瘤侵犯骨髓的形态学及免疫表型分析[J]. 临床与实验病理学杂志, 2016, 32(9): 980-984.
|
[30]
|
殷仁斌, 刘玉霞, 任伟丹, 等. 经典型霍奇金淋巴瘤累及骨髓的临床病理分析[J]. 诊断病理学杂志, 2020, 27(10): 702-705.
|
[31]
|
Zhang, Q.-Y. and Foucar, K. (2009) Bone Marrow Involvement by Hodgkin and Non-Hodgkin Lymphomas. Hematology/Oncology Clinics of North America, 23, 873-902. https://doi.org/10.1016/j.hoc.2009.04.014
|
[32]
|
Solal-Céligny, P., Roy, P., Colombat, P., et al. (2004) Follicular Lymphoma International Prognostic Index. Blood, 104, 1258-1265. https://doi.org/10.1182/blood-2003-12-4434
|
[33]
|
Zhou, Z., Sehn, L.H., Rademaker, A.W., et al. (2014) An En-hanced International Prognostic Index (NCCN-IPI) for Patients with Diffuse Large B-Cell Lymphoma Treated in the Rituximab Era. Blood, 123, 837-842.
https://doi.org/10.1182/blood-2013-09-524108
|
[34]
|
Berget, E., Helgeland, L., Liseth, K., et al. (2014) Prognostic Value of Bone Marrow Involvement by Clonal Immunoglobulin Gene Rearrangements in Follicular Lymphoma. Journal of Clinical Pathology, 67, 1072-1077.
https://doi.org/10.1136/jclinpath-2014-202382
|
[35]
|
Greenbaum, U., Levi, I., Madmoni, O., et al. (2019) The Prognostic Significance of Bone Marrow Involvement in Diffuse Large B Cell Lymphoma According to the Flow Cy-tometry. Leukemia & Lymphoma, 60, 2477-2482.
https://doi.org/10.1080/10428194.2019.1587755
|
[36]
|
Canioni, D., Brice, P., Lepage, E., et al. (2004) Bone Mar-row Histological Patterns Can Predict Survival of Patients with Grade 1 or 2 Follicular Lymphoma: A Study from the Groupe d’Etude des Lymphomes Folliculaires. British Journal of Haematology, 126, 364-371. https://doi.org/10.1111/j.1365-2141.2004.05046.x
|
[37]
|
陈辉树. 淋巴瘤侵犯骨髓的诊断[J]. 中国实用内科杂志, 2006, 26(6): 404-407.
|